Answers are grounded in this paper and cite their sources.
The tumor microenvironment (TME) is a complex ecoystem that invovles cancer cells, immune and stromal cells, in addition to extracellular matrix and secreted factors. The interactions within this complex ecosystem regulate tumor cell phenotypes and direct cancer progression, making their understandingessential for advancing our knowledge of cancer biology and developing innovative treatments. Since standard culture conditions however cannot account for the complexity of the TME, organ-on-a-chip (OOC) technologies have been developed to fill this need. Here, we describe recent advances in OOCs designed to improve in vitro models of the TME by controlling the physical, chemical, geometrical and biological environment of tumor cells. We begin with studies that leverage OOCs to understand cancer biology, followed by a description of works that test drug effects within the TME. Finally, we discuss future avenues for development that will enhance the interest of OOCs for diverse applications, including clinical testing.
No takes yet. Share an insight, caveat, or question.
Bonnet et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: